CryoEM for Drug Discovery

Cryo-electron microscopy (cryoEM) is a Nobel Prize-winning technique for solving high-resolution three-dimensional structures of biological molecules such as proteins, that is used for structure-based drug design. Key to the success of cryoEM are significant advances in high performance computer vision and machine learning algorithms, used to extract information from large numbers of noisy 2D microscope images and compute and refine 3D structures of target proteins in near-native states.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Coming Down the DSCSA Stretch – Authorized Trading Partners, and What You Need to Know

The Drug Supply Chain Security Act (DSCSA) has its final deadline approaching in November 2023. To confirm that only trusted entities are involved in the exchange of prescription drugs, one of the lesser thought-about elements mandates that the required data exchange through the supply chain is only done with authorized and registered trading partners.
Watch Now

Increasing Efficiency in the Pharma Analytical Workflow through Standards and Reference Materials

europeanpharmaceuticalreview

The mechanism of headspace SPME will be explained in detail. Methods for enhancing extraction efficiency will be described. Advantages of headspace SPME over other common extraction methods will be highlighted.
Watch Now

Use of Cannabis in Medicine - Drug or Drug?

MedCram

In the webinar, Prof. Kirsten Müller-Vahl gives an overview of the use of cannabis in medicine, explains the basics of the endocannabinoid system and introduces the various cannabis compounds - from different cannabis flowers to cannabis-based drugs based on extracts and synthetic cannabinoids.
Watch Now

3DP Dosage Forms and the Future of Drug Lifecycle Management

webcasts

Pharmaceutical companies and their drugs face numerous challenges in the brief window between launch and patent expiration. This makes it extremely important to plan lifecycle management (LCM) strategies well in advance of patent expiry. One way to address this is with advanced manufacturing techniques that make it much more difficult for competitors to genericize. For pharmaceutical companies that seek market enhancement strategies beyond the capabilities of existing fast melt technologies, join Contract Pharma for this webinar as we hear from Don Wetherhold, the senior executive advisor and senior vice president of Aprecia Pharmaceuticals. He will talk about the company’s innovative ZipDose technology and why it offers an exclusive opportunity to address patient demand and create products not easily genericized.
Watch Now

Spotlight

resources